Cell-based therapy for liver diseases

European Review for Medical and Pharmacological Sciences

Volumn 7, Issue 2, 2003, Pages 41-44

  Di Campli, C ^a   Nestola, M ^a   Piscaglia, A C ^a   Santoliquido, A ^a   Gasbarrini, G ^a   Pola, P ^a   Gasbarrini, A ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Gene therapy; Hepatocyte transplantation; Liver diseases; MARS

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; CELL TRANSPLANTATION; CONTROLLED STUDY; DNA MODIFICATION; GENE FUNCTION; GENE MUTATION; GENE THERAPY; HUMAN; IMMUNOGENICITY; LIVER CELL; LIVER DISEASE; LIVER FAILURE; LIVER FUNCTION; LIVER METABOLISM; LIVER REGENERATION; LIVER TRANSPLANTATION; MOUSE; NONHUMAN; RAT; REVIEW; STEM CELL;

CELL TRANSPLANTATION; HEPATOCYTES; HUMANS; LIVER FAILURE, ACUTE; LIVER, ARTIFICIAL;

EID: 0042810797     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Di Campli C, Zileri Dal Verme L, Andrisani MC, et al. Advances in extracorporeal detoxification by MARS dialysis in patients with liver failure. Curr Med Chem 2003; 10: 341-348.
2. Allen JW, Hassanein T, Bathia SN. Advances in bioartificial liver devices. Hepatology 2001; 34: 447-455.
3. Fox IJ, Chowdhury JR, Kaufman SS, et al. Treatment of the Cliger-Najjar syndrome type 1 with hepatocytes transplantation. N Engl J Med 1998; 338: 1422-1426.
4. Muraca M, Gerunda G, Neri D, et al. Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 2002; 359: 317-318.
5. Reyes J, Rubenstein WS, Mieles L, et al. The use of cultured hepatocytes infusion via the portal vein for the treatment of ornithine transcarbamylase deficiency by transplantation of enzymatically competent AB0/Rh-matched cells. Hepatology 1996; 24: Suppl: 308A.
6. Stange J, Hassanein TI, Mehta R, Mitzner SR, Bartlett RH. The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers. Artif Organs 2002; 26: 103-110.
7. Klammt S, Stange J, Mitzner S, Peszynski P, Peters E, Liebe S. Extracorporeal liver support by recirculating albumin dialysis: analysing the effect of the first clinically used generation of the MARSystem. Liver 2002; 22 Suppl 2: 30-34.
8. Di Campli C, Gaspari R, Mignani V, et al. Successfull MARS treatment in severe cholestatic patients with acute and acute on chronic liver failure. Artificial Organs 2003; in press.
9. Di Campli C, Wu J, Zern MA. Targeting of therapeutics to the liver: liposomes and viral vectors. Alcohol Clin Exp Res 1999; 23: 950-954.
10. Di Campli C, Wu J, Gasbarrini A, Gasbarrini G, Zern MA. Gene therapy for human liver diseases. Eur J Gastroenterol Hepatol 1999; 11: 421-429.
11. Lowes KN, Croager EJ, Olynyk JK, Abraham LJ, Yeoh GCT. Oval cell-mediated liver regeneration: role of cytokines and growth factors. J Gastroenterol Hepatol 2003; 18: 4-12
12. Piscaglia AC, Di Campli C, Pola P, Gasbarrini A. When biology bursts into the clinic: stem cells and their potential. Eur Rev Med Pharmacol Sci 2001; 5: 151-154.
13. Piscaglia AC, Di Campli C, Pola P, Gasbarrini A. Stem Cells: new tools in gastroenterology and hepatology. Dig Liv Dis 2003, in press.
14. Oh SH, Miyazaki M, Kouchi H, et al. Hepatocyte growth factor induces differentiation of adult bone marrow cells into hepatocyte lineage, in vitro. Biochem Biophys Res Comm 2000; 279: 500-504.
15. Miyazaki M, Akiyama I, Sakguchi M, et al. Improved conditions to induce hepatocytes from rat bone marrow in Culture. Biochem Biophys Res Comm 2002; 298: 24-30.
16. Petersen BE, Bowen WC, Patrene KD, et al. Bone marrow as a potential source of hepatic oval cells. Science 1999; 284: 1168-1170.
17. Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nature Med 2000; 6: 1229-1234.
18. Wang X, Ge S, McManara G, Hao QL, Crooks GM, Nolta JA. Albumin expressing hepatocyte-like cells develop in the livers of immune deficient mice transplanted with highly purified human hematopoietic stem cells. Blood 2003;101: 4201-4208.
19. Theise ND, Nimmakalu M, Gardner R, et al. Liver form bone marrow in humans. Hepatology 2000; 32: 11-16.
20. Korbling M, Katz RL, Khanna A, et al. Hepatocytes and epithelial cells of donor origin in recipients of peripheral blood stem cells. N Eng J Med 2002; 346: 738-746.
21. Grompe M. Liver repopulation for the treatment of metabolic diseases. J Inherit Metabol Dis 2001; 24: 231-234.
22. Feldmann G. Liver transplantation of hepatic stem cells: potential use for treating liver diseases. Cell Biol Toxicol 2001; 17: 77-85.
23. Strom S, Fisher R. Hepatocyte transplantation: new possibilities for therapy. Gastroenterology 2003; 124: 568-571.
24. Sakamoto T, Ye Q, Lu L, Demetris AJ, Starlz TE, Murase N. Donor haematopoietic progenitor cells in nonmyeloablated rat recipients of allogeneic bone marrow and liver grafts. Transplantation 1999; 27: 833-840.
25. Ricordi C, Karatzas T, Nery J, et al. High-dose donor bone marrow infusions to enhance allograft survival: the effect of timing. Transplantation 1997; 63: 7-11.
26. De Haan A, Van Den Berg AP, Van Der Bu W, et al. Rapid decrease in donor-specific cytotoxic T lymphocyte precursor frequencies and graft outcome after liver and lung transplantation. Transplantation 2001; 71: 785-791.